Literature DB >> 8687196

Cerebrovascular complications of Fabry's disease.

P Mitsias1, S R Levine.   

Abstract

Fabry's disease (FD) is a rare, sex-linked disorder resulting from alpha-galactosidase deficiency. Cerebrovascular complications have been reported in the literature but have not been systematically analyzed. We report 2 patients and review 51 previously reported cases (descriptive meta-analysis) to clarify the clinical, radiologic, and pathologic features. The average age at onset of cerebrovascular symptoms was 33.8 years for hemizygous individuals (n = 43) and 40.3 years of heterozygotes (n = 10). The most frequent symptoms and signs were as follows (in descending order of frequency): hemiparesis, vertigo/dizziness, diplopia, dysarthria, nystagmus, nausea/vomiting, head pain, hemiataxia, and ataxia of gait, in the hemizygote group; and memory loss, dizziness, ataxia, hemiparesis, loss of consciousness and hemisensory symptoms, in the heterozygote group. The vertebrobasilar circulation was symptomatic in 67% of the hemizygotes and 60% of the heterozygotes. Intracerebral hemorrhage was found in 4 patients (3 hemizygotes and 1 heterozygote). Elongated, ectatic, tortuous vertebral and basilar arteries were the most common angiographic and pathologic features. For the hemizygotes, the recurrence rate for cerebrovascular disease was 76% and the death rate was 55%; 86% of the heterozygotes had recurrent cerebrovascular event(s) and 40% died. The cerebrovascular manifestations of FD, in both hemizygotes and heterozygotes, are predominantly due to dilative arteriopathy of the vertebrobasilar circulation, frequently recur, and portend a poor prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8687196     DOI: 10.1002/ana.410400105

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  59 in total

1.  Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Authors:  Andreas Fellgiebel; Dominik O Wolf; Edwin Kolodny; Matthias J Müller
Journal:  J Inherit Metab Dis       Date:  2011-09-20       Impact factor: 4.982

2.  Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease.

Authors:  David F Moore; Frank Ye; Raphael Schiffmann; John A Butman
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

3.  Enhanced endothelium-dependent vasodilation in Fabry disease.

Authors:  G Altarescu; D F Moore; R Pursley; U Campia; S Goldstein; M Bryant; J A Panza; R Schiffmann
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

4.  A report of two cases with dolichosegmental intracranial arteries as a new feature of PHACES syndrome.

Authors:  Carlos E Baccin; Timo Krings; Hortensia Alvarez; Augustin Ozanne; Pierre L Lasjaunias
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

Review 5.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.

Authors:  Andreas Fellgiebel; Martin Mazanek; Catharina Whybra; Michael Beck; Ralf Hartung; Kay-Maria Müller; Armin Scheurich; Paulo R Dellani; Peter Stoeter; Matthias J Müller
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 7.  Progressive hearing loss in Fabry's disease: a case report.

Authors:  Florian M Barras; Raphaël Maire
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-07       Impact factor: 2.503

8.  [Fabry's disease: new therapeutic options for this lysosomal storage disorder].

Authors:  A J Grau; M Schwaninger; H H Goebel; M Beck
Journal:  Nervenarzt       Date:  2003-05-20       Impact factor: 1.214

Review 9.  Enzyme replacement therapy of Fabry disease.

Authors:  Joe T R Clarke; R Mark Iwanochko
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

10.  Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.

Authors:  David F Moore; Monique P Gelderman; Paulo A Ferreira; Steven R Fuhrmann; Haiqing Yi; Abdel Elkahloun; Lisa M Lix; Roscoe O Brady; Raphael Schiffmann; Ehud Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.